Interleukin-1β activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: Implications for Alzheimer's disease

Neuroscience

Volumn 91, Issue 3, 1999, Pages 831-842

  Casamenti, F ^a   Prosperi, C ^a   Scali, C ^a   Giovannelli, L ^a   Colivicchi, M A ^a   Faussone Pellegrini, M S ^a   Pepeu, G ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Interleukin 1 ; Neurotransmitter release; Nitric oxide; Nucleus basalis; Rats; Reactive glia

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; GLUTAMIC ACID; INTERLEUKIN 1BETA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; INTERLEUKIN 1;

4 AMINOBUTYRIC ACID RELEASE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL STRUCTURE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FOREBRAIN; GLIA CELL; IMMUNOREACTIVITY; MALE; MICRODIALYSIS; MICROGLIA; NEUROTRANSMITTER RELEASE; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; BRAIN CORTEX; CYTOLOGY; DRUG EFFECT; ECHOGRAPHY; EXTRACELLULAR SPACE; GLIA; IMMUNOHISTOCHEMISTRY; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; WISTAR RAT;

ACETYLCHOLINE; ALZHEIMER DISEASE; ANIMALS; CEREBRAL CORTEX; EXTRACELLULAR SPACE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; MALE; MOTOR ACTIVITY; NEUROGLIA; NITRIC OXIDE; PROSENCEPHALON; RATS; RATS, WISTAR;

EID: 0032587025     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00680-0     Document Type: Article

References (58)

1. Balasingam V., Tejada-Berges T., Wright E., Bouckova R., Yong V.W Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J. Neurosci. 14:1994;846-856.
2. Banati R.B, Gehrmann J., Schubert P., Kreutzberg G.W Cytotoxicity of microglia. Glia. 7:1993;111-118.
3. Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Lodi Rizzini B., Pozzan T., Volterra A. Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature. 391:1998;281-285.
4. Breitner J.C.S., Gau B.A, Welsh K.A, Plassman B.L, McDonald W.M, Helms M.J, Antony J.C Inverse association of antiinflammatory treatments with Alzheimer's disease: initial results of a co-twin control study. Neurology. 44:1994;227-232.
5. Breitner J.C.S., Welsh K.A, Helms M.J, Gaskell P.C, Gau B.A, Roses A.D, Pericak-Vance M.A, Saunders A.M Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging. 16:1995;523-530.
6. Cacabelos R., Barquero M., Garcia P., Alvarez X.A, Varela de Seijas E. Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders. Meth. Find. exp. clin. Pharmac. 13:1991;455-458.
7. Casamenti F., Scali C., Pepeu G. Phosphatidylserine reverses the age-dependent decrease in cortical acetylcholine release: a microdialysis study. Eur. J. Pharmac. 194:1991;11-16.
8. Chao C.C, Hu S., Sheng W.S, Bu D., Bukrinsky M.I, Peterson P.K Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia. 16:1996;276-284.
9. Eddleston M., Mucke L. Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience. 54:1993;15-36.
10. Fisher R.S, Buchwald N.A, Hull C.D, Levine M.S GABAergic basal forebrain neurons project to the neocortex: the localization of glutamic acid decarboxylase and choline acetyltransferase in feline corticopetal neurons. J. comp. Neurol. 272:1988;489-502.
11. Freund T.F, Gulyàs A.I GABAergic interneurons containing calbindin D28K or somatostatin are major targets of GABAergic basal forebrain afferents in the rat neocortex. J. comp. Neurol. 314:1991;187-199.
12. Giovannelli L., Casamenti F., Scali C., Bartolini L., Pepeu G. Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience. 66:1995;781-792.
13. Giovannelli L., Scali C., Faussone-Pellegrini M.S, Pepeu G., Casamenti F. Long-term changes in the aggregation state and toxic effects of β-amyloid injected into the rat brain. Neuroscience. 87:1998;349-357.
14. Giovannini M.G, Bartolini L., Kopf S.R, Pepeu G. Acetylcholine release from the frontal cortex during exploratory activity. Brain Res. 784:1998;218-227.
15. Giulian D., Woodward J., Young D.G, Krebs J.F, Lachman L.B Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8:1988;2485-2490.
16. 15N]nitrate in biological fluids. Analyt. Biochem. 126:1982;131-138.
17. Griffin W.S.T., Sheng J.G, Royston M.C, Gentleman S.M, McKenzie J.E, Graham D.I, Roberts G.W, Mrak R.E Glial-neuronal interactions in Alzheimer' disease: the potential role of a 'Cytokine Cycle' in disease progression. Brain Path. 8:1998;65-72.
18. Griffin W.S.T., Stanley L.C, Ling C., White C.L, MacLeod V., Perrot L.J, White C., Araoz C. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc. natn. Acad. Sci. U.S.A. 86:1989;7611-7615.
19. Grima G., Benz B., Quang Do K. Glutamate-induced release of the nitric oxide precursor, arginine, from glial cells. Eur. J. Neurosci. 9:1997;2248-2258.
20. Gritti I., Mainville L., Jones B.E Codistribution of GABA- with acetylcholine-synthesizing neurons in the basal forebrain of the rats. J. comp. Neurol. 329:1993;438-457.
21. Hardy J., Cowburn R., Barton A., Reynolds G., Dodd P., Wester P., O'Carroll A.M, Lofdahl E., Winblad B. A disorder of cortical GABAergic innervation in Alzheimer's disease. Neurosci. Lett. 73:1987;192-196.
22. Hedlich A., Luth H.J, Werner L., Bar B., Hanisch U., Winkelmann E. GABAergic NADPH-diaphorase-positive Martinotti cells in the visual cortex in rats. J. Hirnforsch. 31:1990;681-687.
23. Kitamura Y., Takahashi H., Matsuoka Y., Tooyama I., Kimura H., Nomura Y., Taniguchi T. In vivo induction of inducible nitric oxide synthase by microinjection with interferon-gamma and lipopolysaccharide in rat hippocampus. Glia. 18:1996;233-243.
24. Klegeris A., Walker D.G, McGeer P.L Activation of macrophages by Alzheimer β amyloid peptide. Biochem. biophys. Res. Commun. 199:1994;984-991.
25. Kreutzberg G.W Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:1996;312-318.
26. Lee S.C, Dickson D.W, Liu W., Brosnan C.F Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon-gamma. J. Neuroimmun. 46:1993;19-24.
27. Lenda K., Sveneby G. Rapid high performance liquid chromatographic determination of amino acids in synaptosomal extracts. J. Chromat. 198:1980;516-519.
28. Mandybur T.I, Chuirazzi B.A Astrocytes and the plaques of Alzheimer's disease. Neurology. 40:1990;635-639.
29. Marczynski T.J GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease; pharmacologic profile of the benzodiazepine antagonist, Flumazenil. Rev. Neurosci. 6:1995;221-258.
30. Marczynski T.J GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease revisited. Brain Res. Bull. 45:1998;341-381.
31. Marshak D.R, Pesce S.A, Stanley L.C, Griffin W.S.T. Increased S100β neurotrophic activity in Alzheimer disease temporal lobe. Neurobiol. Aging. 13:1991;1-7.
32. McCann S.M The nitric oxide hypothesis of brain aging. Expl Gerontol. 32:1997;431-440.
33. McGeer P.L, McGeer E.G The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:1995;195-218.
34. Meda L., Cassatella M.A, Szendrei G.I, Otvos J.L, Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglia cells by β-amyloid protein and interferon-gamma. Nature. 374:1995;647-650.
35. Merrill J.E, Benveniste E.N Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19:1996;331-338.
36. Mesulam M.M, Mufson E.J, Vainer B.H, Levey A.I Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience. 10:1983;1185-1201.
37. Minghetti L., Polazzi E., Nicolini A., Crèminon C., Levi G. Interferon-gamma and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression. J. Neurochem. 65:1996;2690-2698.
38. Mollace V., Nisticò G. Release of nitric oxide from astroglial cells - a key mechanism in neuroimmune disorders. Adv. Neuroimmun. 5:1995;421-430.
39. Mrak R.E, Sheng J.G, Griffin W.S.T. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Human Path. 26:1995;816-823.
40. Murphy S., Guzybicki D. Glial NO. Normal and pathological roles. Neuroscientist. 2:1996;90-99.
41. Murphy S., Simmons M.L, Aqullo L., Garcia A., Feistein D.L, Galea E., Reis D.J, Minc-Golomb D., Schwartz J.P Synthesis of nitric oxide in CNS glial cells. Trends Neurosci. 10:1993;323-328.
42. O'Mahony S., Harkany T., Rensink A.A.M., Abraham I., De Jong G.I, Varga J.L, Zarandi M., Penke B., Nyakas C., Luiten P.G.M., Leonard B.E β-Amyloid-induced cholinergic denervation correlates with enhanced nitric oxide synthase activity in rat cerebral cortex: reversal by NMDA receptor blockade. Brain Res. Bull. 45:1998;405-411.
43. Paxinos G. and Watson G. (1982) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
44. Perlmutter L.S, Scott S.A, Chui H.C The role of microglia in the cortical neuropathology of Alzheimer disease. Bull. clin. Neurosci. 56:1991;120-130.
45. Reinikainen K.J, Piliarvi L., Huuskonen M., Soinen H., Laakso M., Riekkinen P.J A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease. J. neurol. Sci. 84:1988;101-116.
46. Romero L.I, Tatro J.B, Field J.A, Reichlin S. Roles of IL-1 and TNF-alpha in endotoxin-induced activation of nitric oxide synthase in cultured rat brain cells. Am. J. Physiol. 270:1996;R326-R332.
47. Royston M.C, Rothwell N.J, Roberts G.W Alzheimer's disease: pathology to potential treatments? Trends pharmac. Sci. 13:1992;131-133.
48. Salvemini D., Misko T.P, Masferrer J.L, Seibert K., Currie M.G, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc. natn. Acad. Sci. U.S.A. 90:1993;7240-7244.
49. Sheng J.G, Ito K., Skinner R.D, Mrak R.E, Rovnaghi C.R, Van Eldik L.J, Griffin S.W.T. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging. 17:1996;761-766.
50. Sheng J.G, Mrak R.E, Griffin W.S.T. S100β protein expression in Alzheimer's disease. Potential role in the pathogenesis of neuritic plaques. J. Neurosci. Res. 39:1994;398-408.
51. Stanley L.C, Mrak R.E, Woody R.C, Perrot L.J, Zhang S.-X., Marshak D.R, Nelson S.J, Griffin W.S.T. Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. J. Neuropath. exp. Neurol. 53:1994;231-238.
52. Stewart W.F, Kawas C., Corrada M., Metter E.J Risk of Alzheimer's disease and duration of NSAID use. Neurology. 48:1997;628-632.
53. Vaucher E., Linville D., Hamel E. Cholinergic basal forebrain projections to nitric oxide synthase-containing neurons in the rat cerebral cortex. Neuroscience. 79:1997;827-836.
54. Vincent S.R Nitric oxide: a radical neurotransmitter in the central nervous system. Prog. Neurobiol. 42:1994;129-160.
55. Walker L.C, Kitt C.A, Struble R.G, Schmechel D.E, Oertel W.H, Cork L.C, Price D.L Glutamic acid decarboxylase-like immunoreactive neurites in senile plaques. Neurosci. Lett. 59:1985;165-169.
56. Wallace M.N, Geddes J.G, Farquhar D.A, Masson M.R Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques. Expl Neurol. 144:1997;266-272.
57. Whitehouse P.J, Price D.L, Satruble R.G, ClarK A.W, Coyle J.T, Delong M.L Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
58. Zaborszky L., Cullinan W. E. and Braun A. (1991) Afferents to basal forebrain cholinergic projection neurons: an update. In The Basal Forebrain (ed. Napier T. C.), pp. 43-100. Plenum, New York.